000 01564nam  2200349zi 4500
0019.901986
003CaOODSP
00520231215155401
006m     o  d f      
007cr |n|||||||||
008210723t20212021onc     ob   f|0| 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH113-27/2021-8E-PDF
24500|aTebuconazole and its associated end-use products : |bconsultation document.
264 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c2021.
264 4|c©2021
300 |a1 online resource (118 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aProposed re-evaluation decision, |x1925-0967 ; |vPRVD2021-08
500 |aIssued also in French under title: Tébuconazole et préparations commerciales connexes : document de consultation.
500 |a"23 July 2021."
504 |aIncludes bibliographical references (pages 105-118).
650 0|aFungicides|xCertification|zCanada.
650 0|aFungicides|xToxicology.
650 0|aFungicides|xEnvironmental aspects.
7101 |aCanada. |bPest Management Regulatory Agency, |eissuing body.
77508|tTébuconazole et préparations commerciales connexes : |w(CaOODSP)9.901988
830#0|aProposed re-evaluation decision (Canada. Pest Management Regulatory Agency)|vPRVD2021-08.|w(CaOODSP)9.505201
85640|qPDF|s1.26 MB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/h113-27/H113-27-2021-8-eng.pdf|z(report)